Nitroso-naphthol quinone-monooxime tautomeric equilibrium revisited: evidence for oximo group isomerization

Synthesis and Characterization of Pt(II) and Pd(II) Complexes with Planar Aromatic Oximes

A series of four Werner-type complexes of Pd(II) and Pt(II) with planar, isomeric conjugated aromatic naphtoquinone oximes were synthesized for the first time. These ligands were 1-oxime-2-naphtoquinone (HL1) and 2-oxime-1-napthoquinone (HL2). Compounds were characterized using thermal analysis, spectroscopic methods, and X-ray analysis. TG/DSC data were collected for pure starting organic ligands, their complexes, and indicated vigorous exothermic decomposition with at ~155 °C for starting HL and ~350 °C for transition metal complexes. Crystal structures for two Pt compounds with 2-oxime-1-quinone were determined and revealed the formation of the cis-geometry complexes and incorporation of molecules of stoichiometric solvents in the lattice: acetonitrile and nitrobenzene. Both solvents of crystallization displayed attractive interactions between their C-H groups and the oxygen atoms of the nitroso groups in complexes, leading to short distances in those fragments. Despite the presence of solvents of inclusion, the overall structure motifs in both compounds represent 1D columnar coordination polymer, in which the PtL2 units are held together via metallophilic interactions, thereby forming ‘Pt-wires’. The Hirshfield surface analysis was performed for both crystallographically characterized complexes. The results showed intermolecular π–π stacking and Pt–Pt interactions among the planar units of both complexes. In addition, the analysis also verified the presence of hydrogen bonding interactions between the platinum unit and solvent molecules. Solid bulk powdery samples of both PtL12 and PtL22 demonstrated pronounced photoluminescence in the near infrared region of spectrum at ~980 nm, being excited in the range of 750–800 nm. The NIR emission was observed only for Pt-complexes and not for pure starting organic ligands or Pd-complexes. Additionally, synthesized Pt-naphtoquinone oximes do not show luminescence in solutions, which suggests the importance of a 1D ‘metal wire’ structure for this process.

Three decades of unveiling the complex chemistry of C-nitroso species with computational chemistry

This review revisits the complex reactivity of C-nitroso derivatives through the synergistic combination of computational and synthetic organic chemistry, with an emphasis on the rationalization of mechanisms and selectivities. 

New drugs for pharmacological extension of replicative life span in normal and progeroid cells

A high-throughput anti-aging drug screen was developed that simultaneously measures senescence-associated β-galactosidase activity and proliferation. Applied to replicatively pre-aged fibroblasts, this screen yielded violuric acid (VA) and 1-naphthoquinone-2-monoxime (N2N1) as its top two hits. These lead compounds extended the replicative life spans of normal and progeroid human cells in a dose-dependent manner and also extended the chronological life spans of mice and C. elegans. They are further shown here to function as redox catalysts in oxidations of NAD(P)H. They thus slow age-related declines in NAD(P)⁺/NAD(P)H ratios. VA participates in non-enzymatic electron transfers from NAD(P)H to oxidized glutathione or peroxides. N2N1 transfers electrons from NAD(P)H to cytochrome c or CoQ₁₀ via NAD(P)H dehydrogenase (quinone) 1 (NQO1). Our results indicate that pharmacologic manipulation of NQO1 activity via redox catalysts may reveal mechanisms of senescence and aging.

Two drugs were discovered that can extend the life spans of normally aged human cells and thus potentially slow human aging. The anti-aging drugs were identified using a novel method that screens drugs across a two-dimensional endpoint space of senescence-associated galactosidase activity as a general axis of aging and ATP as an axis representing proliferation. The two most potent substances were, likely more than coincidentally, electrons carriers that transfer electrons from NAD(P)H to molecules and cellular structures that demand reducing power to repair oxidative damage that accumulates with aging. Treatment of single cells and whole organisms with these new anti-aging drugs increased their lifespans. The mechanism of the drug action may advance our understanding of the complex, yet resolvable, biological process of aging.

Oximes in the Isoxazolone, Pyrazolone, and 1,2,3-Triazolone Series: Experimental and Computational Investigation of Energies and Structures of E/Z Isomers of α-Oxo-Oximes in the Gas Phase and in Solution

The structures of a series of heterocyclic α-oxo-oximes, viz. 4-oximinoisoxazolone-5(4H)-ones 1 and 2,4-oximino-5(4H)-pyrazolones 3–5, and 4-oximino-1-phenyl-1,2,3-triazol-5(4H)-one 6, were investigated experimentally and computationally. Whereas the intramolecularly H-bonded ZZ isomers of these oximes are usually the most stable in the gas phase, this preference is overcome by intermolecular H-bonding to a solvent or another molecule. For 1,3-dimethyl-4-oximino-5(4H)-pyrazolone 3b a turnaround is seen when going from the solid (predominantly Z isomer) to DMSO solution (predominantly E isomer), which can be ascribed to an intermolecular H-bond between the oxime OH function and a DMSO molecule. Such isomerization is not seen in CDCl3, where intermolecular H-bonding is unimportant. The Z/E-isomerization in DMSO solution is accelerated by photolysis. Calculations of the energies of different conformers, and of 13C NMR data at the GIAO-ωb97xD/6-31G(d)//M06-2X/6-311++G(d,p) level permit a clear-cut correlation of conformer structures with observed 13C NMR spectra.

DFT study on the oxygen transfer mechanism in nitroethenediamine based H2-receptor antagonists using the bis-dithiolene complex as the model catalyst for N-oxide reductase enzyme

Nitroethenediamine is an important functional unit, which is present in H2-receptor antagonists. These drugs show low bioavailability due to the bacterial degradation caused by the N-oxide reductase type of enzymes present in the human colon. Quantum chemical studies have been carried out to elucidate the mechanism of metabolic degradation of nitroethenediamine in the active site of N-oxide reductase. Three different pathways have been explored for the N-oxide bond cleavage by the model system, Mo(IV) bis-dithiolene complex [Mo(OMe)(mdt)2](-), (where mdt=1,2-dimethyl-ethene-1,2-dithiolate) using B3LYP/6-311+G(d,p) and M06/6-311+G(d,p) Density Functional Theory methods. The oxygen atom transfer from the nitrogen atom of nitroethenediamine to the Mo(IV) complex, involves simultaneous weakening of the N-oxide bond and the formation of Mo-O bond through a least motion path. During this transfer, Mo center is converted from a square pyramidal geometry to a distorted octahedral geometry, to facilitate the process of oxygen atom transfer. The energy barrier for the oxygen atom transfer from the imine tautomer has been estimated to be 25.9kcal/mol however, the overall reaction has been found to be endothermic. On the other hand, oxygen transfer reaction from the nitronic acid tautomer requires 30.5kcal/mol energy leading to a highly exothermic metabolite (M-1) directly hence, this path can be considered thermodynamically favorable for this metabolite. The alternative path involving the oxygen atom transfer from the enamine tautomer requires comparatively a higher energy barrier (32.6kcal/mol) and leads to a slightly endothermic metabolite. This study established the structural and energetic details associated with the Mo(IV) bis-dithiolene complex that catalyzes the degradation of nitroethenediamine based drug molecules.